← All trials
NCT04467203
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 28, 2019
- Primary completion
- May 14, 2019
- Completion date
- Jun 28, 2019
- First posted
- Jul 10, 2020
- Last posted
- Jul 10, 2020
- Enrollment
- 14
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Sihuan Pharmaceutical Holdings Group Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.